Simplex Trading
NAGE

Simplex Trading’s Niagen Bioscience NAGE Stock Holding History

Simplex Trading’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$118K Buy
26,677
+2,015
+8% +$10.9K ﹤0.01% 4897
2025
Q4 		$157K Buy
24,662
+264
+1% +$1.84K ﹤0.01% 4478
2025
Q3 		$227K Buy
+24,398
New +$246K ﹤0.01% 4786
2025
Q2 		– Sell
-2,291
Closed -$22.6K – 9976
2025
Q1 		$15K Buy
+2,291
New +$14.4K ﹤0.01% 6819
2024
Q4 		– Sell
-10,533
Closed -$57.7K – 9859
2024
Q3 		$38K Buy
10,533
+1,229
+13% +$3.87K ﹤0.01% 6151
2024
Q2 		$25K Buy
+9,304
New +$31.1K ﹤0.01% 6719
2024
Q1 		– Sell
-553
Closed -$1.02K – 10127
2023
Q4 		$0 Buy
+553
New +$770 ﹤0.01% 10047
2023
Q3 		– Sell
-28,873
Closed -$45.1K – 10067
2023
Q2 		$45K Buy
28,873
+19,503
+208% +$29.1K ﹤0.01% 5952
2023
Q1 		$14K Sell
9,370
-789
-8% -$1.41K ﹤0.01% 7276
2022
Q4 		$17K Sell
10,159
-4,156
-29% -$6.59K ﹤0.01% 7056
2022
Q3 		$17K Sell
14,315
-13,891
-49% -$22.4K ﹤0.01% 7716
2022
Q2 		$47K Buy
28,206
+18,703
+197% +$36.6K ﹤0.01% 6597
2022
Q1 		$23K Buy
9,503
+793
+9% +$2.17K ﹤0.01% 8118
2021
Q4 		$32K Buy
8,710
+2,497
+40% +$13.5K ﹤0.01% 7828
2021
Q3 		$60K Sell
6,213
-3,001
-33% -$24.7K ﹤0.01% 7309
2021
Q2 		$90K Sell
9,214
-13,269
-59% -$116K ﹤0.01% 6883
2021
Q1 		$209K Buy
+22,483
New +$178K ﹤0.01% 4679
2020
Q1 		– Sell
-71
Closed -$273 – 8418
2019
Q4 		$0 Buy
+71
New +$252 ﹤0.01% 8095
2019
Q3 		– Sell
-1,200
Closed -$5.12K – 8013
2019
Q2 		$5K Buy
+1,200
New +$5.12K ﹤0.01% 6487
2018
Q4 		– Sell
-3,264
Closed -$14K – 7968
2018
Q3 		$14K Buy
+3,264
New +$14K ﹤0.01% 6245
2017
Q3 		– Sell
-822
Closed -$3K – 6795
2017
Q2 		$3K Buy
+822
New +$2.6K ﹤0.01% 5066
2016
Q3 		– Sell
-252
Closed -$1K – 6576
2016
Q2 		$1K Buy
+252
New +$1.19K ﹤0.01% 5486

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Simplex Trading's NAGE Position: Q1 2026 in Review

Simplex Trading increased its Niagen Bioscience (NAGE) stake by 8.2% in Q1 2026, buying an estimated $10.9K and bringing the position to 26,677 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #4897.

Simplex Trading first reported a position in NAGE in Q2 2016 and has held it in 22 quarters since. The position peaked at $227K in Q3 2025. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • Simplex Trading held 26,677 shares of Niagen Bioscience worth $118K as of Q1 2026.
  • Simplex Trading bought 2,015 Niagen Bioscience shares in Q1 2026, an estimated $10.9K.
  • Niagen Bioscience made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4897 holding.
  • Simplex Trading first reported a position in Niagen Bioscience in Q2 2016 and has held it in 22 quarters since.
  • Simplex Trading's Niagen Bioscience position peaked at $227K in Q3 2025.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.